Renata Limited

Renata Limited, established in 1972, is a leading pharmaceutical and animal health product manufacturing company headquartered in Dhaka, Bangladesh. Originally founded as Pfizer Bangladesh, it underwent a significant ownership and name change in 1993 to become Renata Limited. Operating within the dynamic Healthcare and Pharmaceuticals sectors, the company is dedicated to the development, production, and distribution of a wide array of medical and health-related solutions for both human and animal populations.

The company's operational scale is underscored by its substantial workforce, ranging from 5,000 to 10,000 employees, and its presence across 2 distinct locations. Renata Limited's comprehensive product catalog includes vital human pharmaceuticals such as synthetic hormones, advanced oncological drugs, and various contraceptives, alongside a robust line of animal health and nutrition products. This broad spectrum of offerings and its dedicated personnel are central to its market impact. Meet Renata Limited's team for further details on their organizational structure and key personnel.

Renata Limited reports significant financial performance, with revenue reaching $274.9M. The company is publicly traded on the Dhaka Stock Exchange under the ticker DSE: RENATA, indicating its established presence and transparency in the financial markets. Its strategic focus on innovation, quality manufacturing, and a dual commitment to human and animal welfare, supported by decades of industry experience, positions Renata Limited as a key player in the Asian healthcare and pharmaceutical landscape.